• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

autoimmune disease

Three darts hitting bullseye
Research

CAR-T drives 3 autoimmune diseases into remission in one patient

After a CAR-T cell therapy reset her immune system, a patient with three different autoimmune diseases is now in remission and back to normal life.
Darren Incorvaia Apr 9, 2026 11:00am
Honeybee sticking head into honeypot

Astellas axes early trial for Sjögren’s syndrome

Mar 30, 2026 2:18pm
Red throne

J&J, Royalty to co-fund $500M autoimmune antibody program

Mar 30, 2026 10:07am
one white and yellow capsule farther ahead than four other same-colored blue capsules

Takeda clears path to FDA with phase 3 data on $4B psoriasis bet

Mar 28, 2026 3:00pm
warning sign

New cancer cases prompt Kyowa to shutter rocatinlimab trials

Mar 3, 2026 11:00am
Bahija Jallal

After R&D head exits, Immunocore CEO pairs ambition with caution

Feb 13, 2026 12:44pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings